Literature DB >> 2564164

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris.

M Packer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564164     DOI: 10.1056/NEJM198903163201107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

Review 1.  Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.

Authors:  William C Stanley; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

Review 2.  Metabolic therapy for heart disease: impact of trimetazidine.

Authors:  Hani N Sabbah; William C Stanley
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

Review 3.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

4.  Slow group beating.

Authors:  D Luke Glancy; Viral N Lathia
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-10

Review 5.  Optimal treatment of angina in older patients.

Authors:  R N Doughty; N Sharpe
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 6.  Therapeutic options in treating acute myocardial infarction.

Authors:  J W Danforth
Journal:  West J Med       Date:  1989-10

7.  Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers.

Authors:  D F Schoors; I Vercruysse; G Musch; D L Massart; A G Dupont
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

8.  [Drug treatment of patients with heart infarcts before and after the acute stage: results of the Heart Infarct Registry Augsburg].

Authors:  M Lewis; H Löwel; A Hörmann
Journal:  Soz Praventivmed       Date:  1994

9.  The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group.

Authors: 
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

10.  Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.

Authors:  S Motomura; K Hashimoto
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.